[et_pb_section fb_built=\u00bb1″ _builder_version=\u00bb4.27.4″ custom_padding=\u00bb0px||||false|false\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb][et_pb_row column_structure=\u00bb2_3,1_3″ _builder_version=\u00bb4.16″ background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_padding=\u00bb0px||0px|||\u00bb global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb][et_pb_column type=\u00bb2_3″ _builder_version=\u00bb4.16″ custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb theme_builder_area=\u00bbpost_content\u00bb][et_pb_image src=\u00bbhttps:\/\/www.mgsmfg.com\/wp-content\/uploads\/2026\/01\/Injection-Hero-retouched-web-update.jpg\u00bb title_text=\u00bbInjection-Hero-retouched-web-update\u00bb disabled_on=\u00bboff|off|on\u00bb _builder_version=\u00bb4.27.6″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb][\/et_pb_image][et_pb_text _builder_version=\u00bb4.27.4″ header_2_font=\u00bb||||||||\u00bb header_2_text_color=\u00bb#00325B\u00bb background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_margin=\u00bb||0px||false|false\u00bb global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb]<\/p>\n
The A.i.r. Platform\u2122 from MGS represents a new era in customizable auto-injector platforms. Built around a flexible core technology, it enables Pharmaceutical partners to develop bespoke, patient-centered devices faster and more cost effectively. Below, we answer the most common questions about how the A.i.r. Platform\u2122 works and why it\u2019s redefining what\u2019s possible in combination product development and manufacturing.<\/strong><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.16″ custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb theme_builder_area=\u00bbpost_content\u00bb][et_pb_image src=\u00bbhttps:\/\/www.mgsmfg.com\/wp-content\/uploads\/2026\/04\/mgs-air-injector-pen-hero-knowledge-center.jpg\u00bb title_text=\u00bbmgs-air-injector-pen-hero-knowledge-center\u00bb disabled_on=\u00bbon|on|off\u00bb _builder_version=\u00bb4.27.6″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb-50%||||false|false\u00bb global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ _builder_version=\u00bb4.27.4″ background_color=\u00bb#e7f3f0″ locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb][et_pb_row column_structure=\u00bb3_4,1_4″ use_custom_gutter=\u00bbon\u00bb gutter_width=\u00bb1″ _builder_version=\u00bb4.27.5″ background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb][et_pb_column type=\u00bb3_4″ _builder_version=\u00bb4.16″ custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb theme_builder_area=\u00bbpost_content\u00bb][et_pb_accordion open_toggle_text_color=\u00bb#1B232A\u00bb open_toggle_background_color=\u00bb#FFFFFF\u00bb closed_toggle_background_color=\u00bb#FFFFFF\u00bb toggle_icon=\u00bb3||divi||400″ icon_color=\u00bb#1B232A\u00bb use_icon_font_size=\u00bbon\u00bb icon_font_size=\u00bb30px\u00bb _builder_version=\u00bb4.27.6″ _module_preset=\u00bbdefault\u00bb toggle_text_color=\u00bb#1B232A\u00bb toggle_font=\u00bb||||||||\u00bb custom_css_toggle=\u00bbmargin-bottom: 20px !important;||\u00bb border_radii=\u00bbon|7px|7px|7px|7px\u00bb border_width_all=\u00bb0px\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb][et_pb_accordion_item title=\u00bbCan auto-injectors like the A.i.r. Platform\u2122 be customized for specific patient populations?\u00bb open=\u00bbon\u00bb _builder_version=\u00bb4.27.6″ _module_preset=\u00bbdefault\u00bb background_color=\u00bb#FFFFFF\u00bb background_enable_color=\u00bbon\u00bb border_color_all=\u00bbRGBA(255,255,255,0)\u00bb global_colors_info=\u00bb{}\u00bb toggle_font_size=\u00bb17px\u00bb theme_builder_area=\u00bbpost_content\u00bb]<\/p>\n Yes, the A.i.r. Platform\u2122 enables you to customize the device to fit your patient needs. In a structured process, MGS Design & Development works with you to design the physical appearance of the device to meet unique patient needs. Our focus is on ensuring patients in your focus area can use the device as intended, even if they are challenged with lower dexterity or low strength. Our team looks at outer shape, surfaces, cap design and adjustments in force \u2013 both for activation and hold force \u2013 to meet specific needs.<\/p>\n The A.i.r. Platform\u2122 also offers continuous audible feedback as an option. By implementing this feature, you are able to improve feedback to the user during injection, reducing risk from early lifts that cause underdosing.<\/p>\n The usability documentation and risk assessment was developed by the MGS team, built on an understanding of 14 typical diseases within subcutaneous drug delivery. Documentation from this platform can easily be adapted to your disease area, saving additional time and cost in finalizing instructions and documentation.<\/p>\n [\/et_pb_accordion_item][et_pb_accordion_item title=\u00bbCan the A.i.r. Platform\u2122 be customized to accommodate different drug profiles, including high viscosity and varying fill volumes?\u00bb _builder_version=\u00bb4.27.6″ _module_preset=\u00bbdefault\u00bb background_color=\u00bb#FFFFFF\u00bb background_enable_color=\u00bbon\u00bb border_color_all=\u00bbRGBA(255,255,255,0)\u00bb global_colors_info=\u00bb{}\u00bb toggle_font_size=\u00bb17px\u00bb theme_builder_area=\u00bbpost_content\u00bb open=\u00bboff\u00bb]<\/p>\n The A.i.r. Platform\u2122 can be customized to accommodate different drug profiles, with key characteristics including viscosity, dose volume and associated injection time requirements. The A.i.r. Platform is designed to accommodate these variables, supporting a wide range of viscosities and fill volumes from 0.3 mL to 2.25 mL. The A.i.r. Platform\u2122 is also customizable to fit any desired Pre-Filled Syringe (PFS).<\/p>\n The following outlines how these key characteristics can be accommodated within the A.i.r. Platform\u2122.<\/p>\n [\/et_pb_accordion_item][et_pb_accordion_item title=\u00bbIs the A.i.r. Platform\u2122 compatible with different prefilled syringe brands and formats?\u00bb _builder_version=\u00bb4.27.6″ _module_preset=\u00bbdefault\u00bb background_color=\u00bb#FFFFFF\u00bb background_enable_color=\u00bbon\u00bb border_color_all=\u00bbRGBA(255,255,255,0)\u00bb global_colors_info=\u00bb{}\u00bb toggle_font_size=\u00bb17px\u00bb theme_builder_area=\u00bbpost_content\u00bb open=\u00bboff\u00bb]<\/p>\n The A.i.r. Platform\u2122 can be customized to any Pre-Filled Syringe (PFS) within the platform\u2019s fill volume of 0.3 to 2.25 mL. If desired, the platform can also be customized to accommodate a cartridge in place of a PFS.<\/p>\n The A.i.r. Platform\u2122 follows this approach by allowing alignment with any PFS brand and formats without requiring a complete device redesign.<\/p>\n [\/et_pb_accordion_item][et_pb_accordion_item title=\u00bbCan the A.i.r. Platform\u2122 be customized to reflect brand identity while meeting usability and regulatory requirements?\u00bb _builder_version=\u00bb4.27.6″ _module_preset=\u00bbdefault\u00bb background_color=\u00bb#FFFFFF\u00bb background_enable_color=\u00bbon\u00bb border_color_all=\u00bbRGBA(255,255,255,0)\u00bb global_colors_info=\u00bb{}\u00bb toggle_font_size=\u00bb17px\u00bb theme_builder_area=\u00bbpost_content\u00bb open=\u00bboff\u00bb]<\/p>\n The A.i.r Platform\u2122 is fully customizable to reflect your unique brand identity. Our designers work with your team to evaluate shape, color(s), embossments and more, helping you build your own device brand to support product marketing efforts.<\/p>\n The look and feel of your auto-injector should reflect both your brand and the patients it serves. Thoughtful design elements like shape, color and finish can help create a more recognizable and cohesive product experience, while reinforcing your understanding of patient needs. Customization also creates opportunities to align with broader brand priorities, such as sustainability or therapy-specific positioning.<\/p>\n In practice, brand expression is typically achieved through changes to visible and tactile elements of the device, while preserving core functionality and validated use conditions. This approach allows companies to differentiate their device appearance without compromising usability or regulatory compliance.<\/p>\n The A.i.r. Platform\u2122 supports this approach by allowing brand-specific design elements to be adapted within an established platform framework.<\/strong><\/p>\n <\/p>\n [\/et_pb_accordion_item][et_pb_accordion_item title=\u00bbHow can MGS\u2019 A.i.r. Platform\u2122 reduce product development timelines?\u00bb _builder_version=\u00bb4.27.6″ _module_preset=\u00bbdefault\u00bb background_color=\u00bb#FFFFFF\u00bb background_enable_color=\u00bbon\u00bb border_color_all=\u00bbRGBA(255,255,255,0)\u00bb global_colors_info=\u00bb{}\u00bb toggle_font_size=\u00bb17px\u00bb theme_builder_area=\u00bbpost_content\u00bb open=\u00bboff\u00bb]<\/p>\n With MGS\u2019 A.i.r. Platform\u2122, you can reduce development timelines by allowing product design and development teams to build on an established foundation rather than designing a device from scratch.<\/p>\n This approach shortens development time by:<\/p>\n As a result, development efforts can move more efficiently from concept to clinical trial and commercial readiness.<\/p>\n [\/et_pb_accordion_item][et_pb_accordion_item title=\u00bbHow can Pharmaceutical companies reduce development and regulatory risk when developing an auto-injector?\u00bb _builder_version=\u00bb4.27.6″ _module_preset=\u00bbdefault\u00bb background_color=\u00bb#FFFFFF\u00bb background_enable_color=\u00bbon\u00bb border_color_all=\u00bbRGBA(255,255,255,0)\u00bb global_colors_info=\u00bb{}\u00bb toggle_font_size=\u00bb17px\u00bb theme_builder_area=\u00bbpost_content\u00bb open=\u00bboff\u00bb]<\/p>\n Pharmaceutical companies can reduce development and regulatory risk when developing an auto-injector by relying on established device approaches and experienced partners, rather than creating entirely new systems.<\/p>\n Through the A.i.r. Platform\u2122, MGS helps you reduce risk with a proven development framework, including usability documentation and completed risk assessments developed from an understanding of 14 disease areas. Leveraging the expertise of MGS\u2019 experienced Design & Development teams, Pharma innovators are able to focus on the drug itself while reducing uncertainty and rework associated with drug delivery device design, testing and manufacturing.<\/p>\n Together, these practices help streamline regulatory interactions and improve the likelihood of successful approval.<\/p>\n [\/et_pb_accordion_item][et_pb_accordion_item title=\u00bbWhat are the key steps to developing our own auto-injector platform? \u00bb _builder_version=\u00bb4.27.6″ _module_preset=\u00bbdefault\u00bb background_color=\u00bb#FFFFFF\u00bb background_enable_color=\u00bbon\u00bb border_color_all=\u00bbRGBA(255,255,255,0)\u00bb global_colors_info=\u00bb{}\u00bb toggle_font_size=\u00bb17px\u00bb theme_builder_area=\u00bbpost_content\u00bb open=\u00bboff\u00bb]<\/p>\n Developing and manufacturing an in-house auto-injector platform typically follows a staged process that builds capacity over time. At MGS, we often begin with a two-week feasibility sprint to evaluate concepts and reduce early risk. From there, development progresses toward initial prototype devices, with timelines tailored to your program and needs.<\/p>\n Key steps include:<\/p>\n Taking a structured, stepped approach helps teams manage complexity while supporting future expansion of the platform.<\/p>\n [\/et_pb_accordion_item][et_pb_accordion_item title=\u00bbHow do you help Pharmaceutical companies reduce auto-injector development costs?\u00bb _builder_version=\u00bb4.27.6″ _module_preset=\u00bbdefault\u00bb background_color=\u00bb#FFFFFF\u00bb background_enable_color=\u00bbon\u00bb border_color_all=\u00bbRGBA(255,255,255,0)\u00bb global_colors_info=\u00bb{}\u00bb toggle_font_size=\u00bb17px\u00bb theme_builder_area=\u00bbpost_content\u00bb open=\u00bboff\u00bb]<\/p>\n Pharmaceutical companies can reduce auto-injector development costs by working with MGS to customize the A.i.r. Platform\u2122 to their unique drug, brand and patient needs. Because MGS has already invested years in developing this platform, that time and cost are removed from your auto-injector development timeline, helping you reach the market faster and more efficiently.<\/p>\n This approach can also support lower complaint rates once your combination product is on the market. When complaints occur, they often trigger investigations, product replacements and additional follow-up activities such as issue documentation and customer communications. Reducing these events helps minimize ongoing costs and operational complexity over the product lifecycle.<\/p>\n [\/et_pb_accordion_item][et_pb_accordion_item title=\u00bbWhat should companies look for in a partner to develop an auto-injector?\u00bb _builder_version=\u00bb4.27.6″ _module_preset=\u00bbdefault\u00bb background_color=\u00bb#FFFFFF\u00bb background_enable_color=\u00bbon\u00bb border_color_all=\u00bbRGBA(255,255,255,0)\u00bb global_colors_info=\u00bb{}\u00bb toggle_font_size=\u00bb17px\u00bb theme_builder_area=\u00bbpost_content\u00bb open=\u00bboff\u00bb]<\/p>\n When selecting a partner to develop an auto-injector, companies should look for an organization with deep, end-to-end experience across drug delivery device design, development and manufacturing.<\/p>\n A strong partner not only brings these end-to-end capabilities but also complements your existing team and helps fill critical gaps needed to reach your goals. This may include a head start through proven platform technologies like the A.i.r. Platform\u2122 and the Intellectual Property (IP) behind it, as well as the expertise required to develop and scale a final device.<\/p>\n A partner like MGS is able to support the full lifecycle of the device from early design optimization and incorporation of usability insights, through tooling development, automation integration and scalable manufacturing. This continuity helps ensure that design decisions made early in development translate reliably into production.<\/p>\n Importantly, that support can extend beyond device development into the next phase, where the device is combined with the drug. Experience in this area helps ensure a more seamless transition and reduces risk as programs move toward commercialization.<\/p>\n Working with a single, experienced manufacturing partner across these stages can help reduce handoffs, minimize development risk and support a more efficient path to commercialization.<\/p>\n This type of integrated platform-based development approach is reflected in offerings such as the A.i.r. Platform\u2122 from MGS.<\/p>\n [\/et_pb_accordion_item][\/et_pb_accordion][\/et_pb_column][et_pb_column type=\u00bb1_4″ _builder_version=\u00bb4.16″ custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb theme_builder_area=\u00bbpost_content\u00bb][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb background_color=\u00bb#00325B\u00bb custom_margin=\u00bb120px||||false|false\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb][et_pb_row column_structure=\u00bb3_5,2_5″ make_equal=\u00bbon\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb][et_pb_column type=\u00bb3_5″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb animation_direction=\u00bbbottom\u00bb global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb][et_pb_image src=\u00bbhttps:\/\/www.mgsmfg.com\/wp-content\/uploads\/2026\/01\/mgs-newsroom-main-thumbnail-AIR.jpg\u00bb title_text=\u00bbmgs-newsroom-main-thumbnail-AIR\u00bb _builder_version=\u00bb4.27.5″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb-150px||||false|false\u00bb animation_style=\u00bbslide\u00bb animation_direction=\u00bbbottom\u00bb animation_duration=\u00bb500ms\u00bb animation_delay=\u00bb300ms\u00bb animation_intensity_slide=\u00bb17%\u00bb animation_speed_curve=\u00bbease-out\u00bb global_colors_info=\u00bb{}\u00bb transform_styles__hover_enabled=\u00bboff|desktop\u00bb transform_scale__hover_enabled=\u00bboff|desktop\u00bb transform_translate__hover=\u00bb0px|-2%\u00bb transform_translate__hover_enabled=\u00bboff|desktop\u00bb transform_rotate__hover_enabled=\u00bboff|desktop\u00bb transform_skew__hover_enabled=\u00bboff|desktop\u00bb transform_origin__hover_enabled=\u00bboff|desktop\u00bb theme_builder_area=\u00bbpost_content\u00bb][\/et_pb_image][\/et_pb_column][et_pb_column type=\u00bb2_5″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb animation_style=\u00bbslide\u00bb animation_direction=\u00bbbottom\u00bb animation_duration=\u00bb700ms\u00bb animation_delay=\u00bb700ms\u00bb animation_intensity_slide=\u00bb17%\u00bb animation_speed_curve=\u00bbease-out\u00bb global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb][et_pb_text _builder_version=\u00bb4.27.5″ _module_preset=\u00bbdefault\u00bb header_2_font=\u00bb||||||||\u00bb header_2_text_color=\u00bb#FFFFFF\u00bb header_2_font_size=\u00bb28px\u00bb header_3_font=\u00bbLato|||on|||||\u00bb header_3_text_color=\u00bb#76cbdf\u00bb header_3_font_size=\u00bb18px\u00bb background_layout=\u00bbdark\u00bb max_width=\u00bb450px\u00bb custom_margin=\u00bb10px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb]<\/p>\n From Design & Development to Tooling, Automation and Manufacturing, our experts have the insights you need to accelerate your auto-injector innovations. Send us a message today to start your drug delivery device development!<\/p>\n Send Us a Message<\/a>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb width=\u00bb100%\u00bb custom_padding=\u00bb0px||0px||true|false\u00bb global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.23″ _module_preset=\u00bbdefault\u00bb background_color=\u00bb#FFFFFF\u00bb border_radii=\u00bbon|7px|7px|7px|7px\u00bb global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb][et_pb_text _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb max_width=\u00bb100%\u00bb global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb]<\/p>\n [\/et_pb_text][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjE0MiJ9fQ==@\u00bb button_text=\u00bbBack to News & Insights\u00bb button_alignment=\u00bbcenter\u00bb _builder_version=\u00bb4.23.1″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb theme_builder_area=\u00bbpost_content\u00bb][\/et_pb_button][et_pb_code _builder_version=\u00bb4.27.6″ _module_preset=\u00bbdefault\u00bb theme_builder_area=\u00bbpost_content\u00bb hover_enabled=\u00bb0″ sticky_enabled=\u00bb0″]\n\n
\n \nDrug Profile Requirement<\/th>\n How the A.i.r. Platform\u2122 Addresses It<\/th>\n Supported Range<\/th>\n<\/tr>\n<\/thead>\n \n Drug viscosity<\/td>\n Power spring and device parts can be customized to support any viscosity within our range.<\/td>\n Suitable for low- to high-viscosity formulations (0-200 cP).<\/td>\n<\/tr>\n \n Fill volumes<\/td>\n Configurable platform supports multiple dose volumes for any PFS within our fill volume range.<\/td>\n 0.3 mL to 2.25 mL fill volumes.<\/td>\n<\/tr>\n \n Injection time<\/td>\n Customizable power spring and device parts meet any injection time requirements.\u00a0<\/td>\n Adjustable to align with drug and patient needs. Supported range: 1-20 seconds.<\/td>\n<\/tr>\n \n Pre-filled syringe (PFS) use<\/td>\n Designed to work with any PFS, including cartridges.\u00a0<\/td>\n Supports any PFS formats and brand within 0.3mL-2.25 mL.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n Brand-Related Elements That Can Be Customized<\/h3>\n
\n\n
\n \nDesign Element<\/th>\n Customization Scope<\/th>\n<\/tr>\n<\/thead>\n \n Device color<\/td>\n The device color can be customized to fit company and\/or drug brand as desired.<\/td>\n<\/tr>\n \n Surface finish<\/td>\n Surfaces can be customized to reflect design DNA and\/or to support user interface with device.<\/td>\n<\/tr>\n \n Body shape<\/td>\n The external form factor (shape and size) of the device can be fully designed to represent company design DNA and be designed around specific user needs.<\/td>\n<\/tr>\n \n Embossments<\/td>\n Logos, symbols and orientation cues can be implemented as desired.<\/td>\n<\/tr>\n \n Injection feedback<\/td>\n The device can be designed to give needed feedback to the specific user population including both audible and visual cues \u2013 i.e., continuous feedback.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n \n
\n
Want to learn more about the A.i.r. Platform\u2122?<\/h2>\n
Share Now<\/h3>\n